Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06678893 · ClinicalTrials.gov registry record · NA
Ear Acupuncture for Pain and Anxiety Management in Early Labor
A NA study, sponsored by Women and Infants Hospital of Rhode Island.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT06678893: Completed NA study, sponsored by Women and Infants Hospital of Rhode Island.
NCT06678893 is a NA study that has completed, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06678893, a NA study, has completed, sponsored by Women and Infants Hospital of Rhode Island.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
This is a study evaluating the feasibility and acceptability of ear acupuncture for the management of pain and anxiety in early labor.
Primary Outcome
The investigators are evaluating if doing a randomized control trial on acupuncture in early labor is feasible in the setting of the Emergency Department of Women and Infants Hospital in Rhode Island by evaluating how many eligible patients consent to being a part of the study
Interventions
- DEVICE Acupuncture Needle on an adhesive
- DEVICE Adhesives
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2024-11-05 |
| Est. Completion | 2025-01-01 |
| Phase | NA |
What the finished NCT06678893 record still lists
NCT06678893 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Acupuncture Needle on an adhesive is the first listed.
NCT06678893 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06678893 about?
NCT06678893 is a clinical study titled "Ear Acupuncture for Pain and Anxiety Management in Early Labor". This is a study evaluating the feasibility and acceptability of ear acupuncture for the management of pain and anxiety in early labor.
What is the current status of trial NCT06678893?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2024-11-05. Estimated completion is 2025-01-01.
What interventions are being tested in trial NCT06678893?
The interventions under investigation include: Acupuncture Needle on an adhesive (DEVICE), Adhesives (DEVICE).
Who is sponsoring clinical trial NCT06678893?
This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06678893's enrollment target sits among peer trials
38 1538th of 2000 higher than 461 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI